Skip to content
Clinical Trials – home

Multiprofile Hospital For Active Treatment Sveti Nikolay Chuditvorets EOOD

Verified siteinfo

Bulgaria Ulitsa Todor Kableshkov 2, 3600 Lom, Bulgaria

  • 3 trials recruiting
  • Arteriosclerosis · Clostridium difficile infection · Diabetic foot infection
  • Adults and children

About Specializations

Multiprofile Hospital For Active Treatment Sveti Nikolay Chuditvorets EOOD in Lom, Bulgaria specialises in clinical trials of conditions such as Arteriosclerosis, Clostridium difficile infection, Diabetic foot infection, Hyperparathyroidism secondary, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Research

The Department of Hemodialysis is conducting a study aimed at improving safety for patients on FXa inhibitors who require urgent surgery, evaluating a reversal agent to quickly stop bleeding.

  • Management of peri‑operative bleeding
  • Evaluation of reversal agents
  • Risk reduction in cardiovascular patients

This work, carried out at Multiprofile Hospital For Active Treatment Sveti Nikolay Chuditvorets EOOD, supports better outcomes for individuals with acute cardiovascular complications.

Hormonal Disease Research

A clinical trial is assessing the effectiveness of a novel therapy, PLS240, in lowering parathyroid hormone levels for patients with secondary hyperparathyroidism undergoing chronic hemodialysis.

  • Reduction of iPTH levels
  • Long‑term safety monitoring
  • Improvement of mineral‑bone health

Findings from this investigation at the Lom facility may enhance treatment strategies for endocrine complications in end‑stage kidney disease.

Female Urogenital and Pregnancy Research

Although the current portfolio emphasizes renal and cardiovascular studies, the department maintains expertise in addressing female urogenital diseases and pregnancy‑related complications within the hemodialysis population.

  • Monitoring of reproductive health in dialysis patients
  • Assessment of pregnancy outcomes
  • Integration of gender‑specific care

The hospital’s multidisciplinary approach ensures comprehensive support for women receiving active treatment.

Male Urogenital Disease Research

The site also explores issues related to male urogenital diseases in patients undergoing dialysis, focusing on hormonal balance and quality of life.

  • Evaluation of testosterone levels
  • Management of sexual dysfunction
  • Coordination with nephrology care

By integrating these considerations, the research aims to improve overall wellbeing for male patients at the hospital.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ulitsa Todor Kableshkov 23600 LomBulgaria
Recruiting now
3 trials
Conditions studied
6
Partner status
Verified site

More sites in LomBulgaria

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

7 clinical trials

Study on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Clazakizumab
  • Sponsor:CSL Behring LLC

Study on VE303 for Preventing Recurrent C. difficile Infection in Patients

Investigational
Countries:BulgariaBulgaria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Bacilli, Cluster Xvii, Strain Relative Clostridium_Aq Innocuum, Live
  • Sponsor:Vedanta Biosciences Inc.

Study on the Safety and Effectiveness of Contezolid Acefosamil, Contezolid, and Linezolid for Adults with Moderate or Severe Diabetic Foot Infections

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Aztreonam
  • Sponsor:Micurx Pharmaceuticals Inc.

Study of single-dose oritavancin safety and tolerability in children with acute bacterial skin and skin structure infections

Registered drugNo placebo
Countries:BulgariaBulgaria
  • Participants:0–17 years
  • Substances:Aztreonam
  • Sponsor:Melinta Therapeutics LLC

Title: Comparison of oral tebipenem pivoxil versus intravenous imipenem-cilastatin in adults with complicated urinary tract infection or acute pyelonephritis

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Cilastatin
  • Sponsor:Spero Therapeutics Inc.

Study on the Effectiveness and Safety of PLS240 for Treating Secondary Hyperparathyroidism in Patients with End Stage Kidney Disease on Hemodialysis

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Upacicalcet Sodium Hydrate
  • Sponsor:Pathalys Pharma Inc.
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Aminocaproic Acid
  • Sponsor:AstraZeneca AB
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.